acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/sumypharma/public_html/wp-includes/functions.php on line 6121It is a selectively and competitively inhibits the hepatic enzyme HMG-CoA reductase, which is responsible for converting HMG-CoA to mevalonate in the cholesterol biosynthesis pathway, this results in a subsequent decrease in hepatic cholesterol levels. The decreased hepatic cholesterol levels stimulate up regulation of hepatic LDL-C receptors which increases hepatic uptake of LDL-C and reduces serum LDL-C concentrations.
Anorexia, alopecia, thrombocytopenia, dizziness, insomnia, bronchitis, rashes, rhinitis, and abdominal cram
Alcohol consumption, liver disease, hypothyroidism, lactation
Hypercholesterolemia, Primary prevention of coronary heart disease
Adult: Initially, 10 or 20 mg daily may increase at 4-week intervals. May increase with 40mg once daily in patient who require 45% reduction of LDL, Max dose 80 mg/day
Child: Initially, 10-80mg daily. Adjust dose based upon the response. Max dose: 20mg daily